Last updated on November 2017

AEWS1031: A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma


Brief description of study

AEWS1031: A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01231906?term=AEWS1031&rank=1

Clinical Study Identifier: TX1898

Contact Investigators or Research Sites near you

Start Over

Patricia Green

Memorial Health University Medical Center
Savannah, GA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.